SOP Bulletin No. 97

Decision Support Unit

Level 8, 259 Queen St, Brisbane — 1st Floor Blackburn House, 199 Grenfell St, Adelaide

Intranet site:  http://intranet/nat/comp/dp/Nop/dsu/dsudefault.htm

31 — st October 2005

RELEASE NOTES - CCPS VERSION 2005/10

Version 2005/10 of the Medical Knowledge Base for CCPS was released into production today.  This Bulletin provides a summary of the new and amended SOPs that this version of CCPS incorporates.  This Bulletin also details changes to some existing rulebases and commentary.

New SOPs incorporated into CCPS	Nil
SOP amendments incorporated into CCPS	Asbestosis Erectile dysfunction Malignant neoplasm of the oral cavity, oropharynx and hypopharynx Seborrhoeic dermatitis
Enhancements of CCPS rulebases and commentary	Acute lymphoid leukaemia Acute myeloid leukaemia Chronic myeloid leukaemia Cirrhosis of the liver Malignant neoplasm of the brain Malignant neoplasm of the breast Malignant neoplasm of the lip epithelium Malignant neoplasm of the liver Malignant neoplasm of the nasopharynx Malignant neoplasm of the oesophagus Malignant neoplasm of the pancreas Malignant neoplasm of the stomach Morbid obesity Multiple sclerosis Soft tissue sarcoma Subarachnoid haemorrhage
Continuous improvement - not noteworthy	Gastro-oesophageal reflux disease Diabetes mellitus Sensori — neural hearing loss and tinnitus

New SOPs incorporated into CCPS

Nil

SOP amendments incorporated into CCPS

Asbestosis

The new respirable asbestos fibres factors are now incorporated.

For information on this SoP refer to SoP Bulletin No. 94 of 18/7/05.

Erectile dysfunction

There are a large number of factors in these SoPs and where possible factors have been combined. If a particular contention can not be found outright then check the following contentions to see if it has been combined:

• A specified disease for erectile dysfunction
• Specified endocrinological disorder for erectile dysfunction
• Other neurological disorder for erectile dysfunction
• Treatment with a drug from the specified lists

This information can be found by clicking on the 'Policy' button on the Contention Management Screen.

For information on this SoP refer to SoP Bulletin No. 93 of 20/6/05.

Malignant neoplasm of the oral cavity, oropharynx and hypopharynx

This SoP has a very long title and the diagnostic label in CCPS should be edited to refer only to the site relevant to the veteran.

For information on this SoP refer to SoP Bulletin No. 93 of 20/6/05.

Seborrhoeic dermatitis

For information on this SoP refer to SoP Bulletin No. 94 of 18/7/05.

Enhancements of CCPS rulebases and commentary

Kattenberg changes have also been made to the following conditions and the factors specified:

• Acute lymphoid leukaemia (atomic radiation)
• Acute myeloid leukaemia (smoking, ionising radiation, benzene, AVGAS)
• Chronic myeloid leukaemia (smoking, atomic radiation)
• Cirrhosis of the liver (carbon tetrachloride, methotrexate, vitamin A)
• Malignant neoplasm of the brain (atomic radiation)
• Malignant neoplasm of the breast (oral contraceptives)
• Malignant neoplasm of the lip epithelium (smoking)
• Malignant neoplasm of the liver (smoking, exposure to aflatoxins)
• Malignant neoplasm of the nasopharynx (wood dust, smoking)
• Malignant neoplasm of the oesophagus (smoking)
• Malignant neoplasm of the pancreas (smoking, DDT)
• Malignant neoplasm of the stomach (smoking, atomic radiation)
• Morbid obesity (excessive caloric intake)
• Multiple sclerosis (organic solvents)
• Soft tissue sarcoma (herbicide, chlorophenol, atomic radiation)
• Subarachnoid haemorrhage (smoking, aspirin)

Continuous Improvement

Changes to the following incorporated conditions are included in this release. However, there are no noteworthy CCPS features:

• Gastro-oesophageal reflux disease
• Diabetes mellitus
• Sensori-neural hearing loss and tinnitus
• Morbid obesity

Remember! If you are having any problems with SOPs, or SOPs in CCPS, talk to us!